BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30821889)

  • 1. Influence of bisphosphonates on clinical features of osteoradionecrosis of the maxilla and mandible.
    Miniello TG; Araújo JP; Silva MLG; Paulo Kowalski L; Rocha AC; Jaguar GC; Abreu Alves F
    Oral Dis; 2019 Jul; 25(5):1344-1351. PubMed ID: 30821889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
    Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.
    Walter C; Grötz KA; Kunkel M; Al-Nawas B
    Support Care Cancer; 2007 Feb; 15(2):197-202. PubMed ID: 16941133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
    Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
    Melo MD; Obeid G
    J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis.
    Wehrhan F; Moebius P; Amann K; Ries J; Preidl R; Neukam FW; Weber M
    J Craniomaxillofac Surg; 2017 Jun; 45(6):944-953. PubMed ID: 28365078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
    Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause and occurrence timing of osteoradionecrosis of the jaw: a retrospective study focusing on prophylactic tooth extraction.
    Wanifuchi S; Akashi M; Ejima Y; Shinomiya H; Minamikawa T; Furudoi S; Otsuki N; Sasaki R; Nibu KI; Komori T
    Oral Maxillofac Surg; 2016 Dec; 20(4):337-342. PubMed ID: 27401528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.
    Polidoro S; Broccoletti R; Campanella G; Di Gaetano C; Menegatti E; Scoletta M; Lerda E; Matullo G; Vineis P; Berardi D; Scully C; Arduino PG
    Mutat Res; 2013 Oct; 757(2):104-13. PubMed ID: 23892139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.
    Zhou Y; Yu Y; Shi Y; Li M; Yang C; Wang S
    Biomed Res Int; 2020; 2020():5847429. PubMed ID: 33123580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
    Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
    J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.